Article
Author(s):
Fort Lauderdale, FL-Latanoprost, bimatoprost, and travoprost have comparable IOP-lowering effectiveness in patients with open-angle glaucoma or ocular hypertension, according to a recent study.
Harrow expands patient access to eyecare medications with price reductions and GoodRx partnership
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
CHMP issues positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform
Integrating imaging modalities for early detection of key microscopic abnormalities in diabetic retinopathy